- Home
- Life Sciences
- Pharmaceutical
- Pharmaceutical Analysis & Statistics in North America Countries, February 2013 (p3)
Talk to Geoffrey
(866) 682 9815
Search inside this page
Publication dates
Publishers
- Global Data (2 866)
- Global Markets Direct (1 773)
- Euromonitor International (75)
- Ibisworld (25)
- Business Monitor International (38)
-
- Global Research & Data Services (43)
- Barnes Reports (32)
- Canadean Ltd (13)
- GBI Research (42)
- ICD Research (102)
- KnowMade (2)
- Aruvian's R'search (10)
- Axis Research Mind (1)
- BCC Research (19)
- Daedal Research (3)
- Firstword Pharma (12)
- Global Industry Analysts (1)
- Infiniti Research Limited (6)
- Koncept Analytics (22)
- Timetric (2)
- TriMark Publications (12)
- Datamonitor (351)
- MarketLine (180)
- Life Science Analytics (LSA) (151)
- Espicom Business Intelligence (74)
- Frost & Sullivan (63)
- Business Review (59)
- Timely Data Resources Inc. (52)
- Global Industry Analyst (49)
- SCRIP Insights (45)
- Mintel (33)
- World Market Intelligence Ltd (29)
- Kalorama Information (25)
- CHI Insight Pharma Reports (24)
- The Assessment Group (19)
- Visiongain (18)
- Freedonia (17)
- VacZine Analytics Group Of Assay Advantage Ltd (14)
- MarketLine Industry Guides (12)
- Sociable Pharma (10)
- RNCOS (9)
- La Merie Publishing (8)
- MarketsandMarkets (8)
- Packaged Facts (8)
- IData Research, Inc. (8)
- Ken Research Private (7)
- ABMRG (6)
- Bioseeker (6)
- Obainfo (4)
- BioPharm Reports (4)
- Apollo Managed Care Consultants (3)
- Arrowhead (3)
- DrugPatentWatch - ThinkBiotech LLC (3)
- Greystone Research Associates (3)
- Leatherhead Food Research (3)
- Renub Research (3)
- Urch Publishing (3)
- BioInformatics (2)
- Pacific Bridge Medical (2)
- Red Mountain Insights (2)
- Venture Planning Group (2)
- Analytiqa (1)
- Arena (1)
- Beremans Ltd (1)
- BioPlan Associates, Inc. (1)
- France Innovation Scientifique et Transfert (1)
- Industry Experts (1)
- Innovative Research and Products (iRAP), Inc. (1)
- International Market Analysis Research and Consult (1)
- PMR Ltd. (1)
- Research In China (1)
- Transparency Market Research (1)
- Verdict Research Ltd (1)
- WinterGreen Research (1)
- Zzz FACT Research (1)
All regions
data types
Free Market Research Guides to Download
Pharmaceutical Analysis & Statistics in North America Countries, February 2013 (p3)
You might be interested in: therapeutics, cancer, drug, more »
» Purchase Premium Reports
61-90 of about 6 400 reports
Zonegran (Epilepsy) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- February 2013
- by Global Data
Zonegran (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Zonegran (Epilepsy) - Forecast and Market Analysis to 2022?. Epilepsy ...
- Industries : Pathology
- Countries : Japan, United States, World, Spain, Italy, France, Germany, India, Europe, United Kingdom, China
Banzel / Inovelon (Epilepsy) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- February 2013
- by Global Data
Banzel / Inovelon (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Banzel / Inovelon (Epilepsy) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : World, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Trobalt/Potiga (Epilepsy) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- February 2013
- by Global Data
Trobalt/Potiga (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Trobalt/Potiga (Epilepsy) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : United States
Zebinix (Epilepsy) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- February 2013
- by Global Data
Zebinix (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Zebinix (Epilepsy) - Forecast and Market Analysis to 2022?. Epilepsy ...
- Industries : Pathology
- Countries : United States, Spain, Italy, France, Germany, India, World, Europe, United Kingdom
Fycompa (Epilepsy) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- February 2013
- by Global Data
Fycompa (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Fycompa (Epilepsy) - Forecast and Market Analysis to 2022?. Epilepsy ...
- Industries : Pathology
- Countries : Japan, United States, Spain, Italy, France, Germany, World, Europe, United Kingdom
Brivaracetam (Epilepsy) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- February 2013
- by Global Data
Brivaracetam (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Brivaracetam (Epilepsy) - Forecast and Market Analysis to 2022?. ...
- Industries : Pathology
- Countries : Spain, Italy, France, Germany, United States, World, Europe, United Kingdom
Ganaxolone (Epilepsy) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- February 2013
- by Global Data
Ganaxolone (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Ganaxolone (Epilepsy) - Forecast and Market Analysis to 2022?. ...
- Industries : Pathology
- Countries : Spain, Italy, France, Germany, United States, World, Europe, United Kingdom
VX-765 (Epilepsy) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- February 2013
- by Global Data
VX-765 (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?VX-765 (Epilepsy) - Forecast and Market Analysis to 2022?. Epilepsy ...
- Industries : Pathology
- Countries : Spain, Italy, France, Germany, United States, World, Europe, United Kingdom
Hemoglobin A1c Testing Markets
- $ 3 400
- Industry report
- March 2013
- by TriMark Publications
Hemoglobin A1c (HbA1c) testing is the most recent major technology to have entered the diabetes testing market. As the global prevalence of diabetes mellitus continues to increase rapidly, with more than ...
- Industries : Pathology
- Countries : United States, World
Global Cardiac Resynchronization Therapy (CRT) Devices - Market Growth Analysis, 2009-2015
- $ 3 270
- Industry report
- April 2013
- by Axis Research Mind
Global Market Watch: The broad ?health care' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac ...
- Industries : Therapy
- Countries : World, United States
PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
- $ 2 995
- Industry report
- April 2013
- by Global Data
PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry Summary "PharmaSphere: Early-Stage Technology ...
- Industries : Drug and Medication
- Countries : United States
Dyskinesia Global Clinical Trials Review, H1, 2013
- $ 2 500
- Industry report
- April 2013
- by Global Data
Dyskinesia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Dyskinesia Global Clinical Trials Review, H1, 2013" provides data on the Dyskinesia clinical trial scenario. ...
- Industries : Drug Discovery and Development
- Countries : World, United States
Anorexia Nervosa Global Clinical Trials Review, H1, 2013
- $ 2 500
- Industry report
- April 2013
- by Global Data
Anorexia Nervosa Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Anorexia Nervosa Global Clinical Trials Review, H1, 2013" provides data on the Anorexia Nervosa clinical ...
- Industries : Drug Discovery and Development
- Countries : World, United States
Psychiatric Disorders - Pipeline Review, H1 2013
- $ 2 500
- Company report
- April 2013
- by Global Markets Direct
Psychiatric Disorders - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Psychiatric Disorders - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This ...
- Industries : Therapy
- Countries : United States
Drug and Medication Industry: Ovarian Cancer - Pipeline Review, H1 2012
- $ 2 500
- Company report
- April 2013
- by Global Markets Direct
This report provides information on the therapeutic development for Ovarian Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : United States
Herpes Simplex Infections Global Clinical Trials Review, H1, 2013
- $ 2 500
- Industry report
- March 2013
- by Global Data
Herpes Simplex Infections Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Herpes Simplex Infections Global Clinical Trials Review, H1, 2013" provides data on the ...
- Industries : Drug Discovery and Development
- Countries : World, United States
Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2013
- $ 2 500
- Industry report
- March 2013
- by Global Data
Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2013" provides data on the Herpes ...
- Industries : Drug Discovery and Development
- Countries : World, United States
Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2013
- $ 2 500
- Industry report
- March 2013
- by Global Data
Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials ...
- Industries : Pathology
- Countries : World, United States
Male Hypogonadism Global Clinical Trials Review, H1, 2013
- $ 2 500
- Industry report
- March 2013
- by Global Data
Male Hypogonadism Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Male Hypogonadism Global Clinical Trials Review, H1, 2013" provides data on the Male Hypogonadism ...
- Industries : Drug Discovery and Development
- Countries : World, United States
Esophageal Achalasia Global Clinical Trials Review, H1, 2013
- $ 2 500
- Industry report
- March 2013
- by Global Data
Esophageal Achalasia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Esophageal Achalasia Global Clinical Trials Review, H1, 2013" provides data on the Esophageal ...
- Industries : Drug Discovery and Development
- Countries : World, United States
Gonorrhea Global Clinical Trials Review, H1, 2013
- $ 2 500
- Industry report
- March 2013
- by Global Data
Gonorrhea Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Gonorrhea Global Clinical Trials Review, H1, 2013" provides data on the Gonorrhea clinical trial scenario. ...
- Industries : Drug Discovery and Development
- Countries : United States, World
Appendicitis Global Clinical Trials Review, H1, 2013
- $ 2 500
- Industry report
- March 2013
- by Global Data
Appendicitis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Appendicitis Global Clinical Trials Review, H1, 2013" provides data on the Appendicitis clinical trial ...
- Industries : Drug Discovery and Development
- Countries : World, United States
Dermatomycoses Global Clinical Trials Review, H1, 2013
- $ 2 500
- Industry report
- March 2013
- by Global Data
Dermatomycoses Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Dermatomycoses Global Clinical Trials Review, H1, 2013" provides data on the Dermatomycoses clinical ...
- Industries : Drug Discovery and Development
- Countries : World, United States
Fatigue Global Clinical Trials Review, H1, 2013
- $ 2 500
- Industry report
- March 2013
- by Global Data
Fatigue Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Fatigue Global Clinical Trials Review, H1, 2013" provides data on the Fatigue clinical trial scenario. This ...
- Industries : Drug Discovery and Development
- Countries : World, United States
Cholestasis Global Clinical Trials Review, H1, 2013
- $ 2 500
- Industry report
- March 2013
- by Global Data
Cholestasis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Cholestasis Global Clinical Trials Review, H1, 2013" provides data on the Cholestasis clinical trial scenario. ...
- Industries : Drug Discovery and Development
- Countries : World, United States
Rosacea Global Clinical Trials Review, H1, 2013
- $ 2 500
- Industry report
- March 2013
- by Global Data
Rosacea Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Rosacea Global Clinical Trials Review, H1, 2013" provides data on the Rosacea clinical trial scenario. This ...
- Industries : Drug Discovery and Development
- Countries : World, United States
Drug and Medication Industry: Prostate Cancer - Pipeline Review, H1 2012
- $ 2 500
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Prostate Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : United States
Cellulitis Global Clinical Trials Review, H1, 2013
- $ 2 500
- Industry report
- March 2013
- by Global Data
Cellulitis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Cellulitis Global Clinical Trials Review, H1, 2013" provides data on the Cellulitis clinical trial scenario. ...
- Industries : Drug Discovery and Development
- Countries : World, United States
Therapy Industry: Alzheimer%s Disease - Pipeline Review, H1 2012
- $ 2 500
- Industry report
- February 2013
- by Global Markets Direct
Alzheimer's Disease - Pipeline Review, H1 2012 What's inside this report? Global Industries Direct's, 'Alzheimer's Disease - Pipeline Review, H1 2012', provides an overview of the Alzheimer's Disease ...
- Industries : Therapy
- Countries : United States
Therapy in United States: Hepatitis C - Pipeline Review, H1 2012
- $ 2 500
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Hepatitis C, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Therapy
- Countries : United States
» Download Public Reports
About 16 000 reports
Company Report: Pathology in The United States and Ireland for Year 2013
- Company report
- May 2013
- 5 pages
- by Corporation
... Involved, even indirectly, with an important therapeutic area that addresses the needs of millions of patients who suffer from respiratory disease is particularly meaningful to all of us at elan." Relvar ...
U.s. Pharmaceutical Industry
May 2013U.s. Vitamin D Sector Analysis
May 2013» Read our Company Profiles
About 200 CompaniesGlaxoSmithKline P.L.C.
United StatesNovartis Inc.
SwitzerlandGlaxoSmithKline PLC
United KingdomJohnson and Johnson
United StatesEli Lilly and Co.
United StatesReportlinker.com © Copyright 2013. All rights reserved.
